| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $308.4M | — | +93.4% |
| Cost of Revenue | $73.2M | — | +82.9% |
| Gross Profit | $235.1M | — | +96.9% |
| R&D Expense | $125.6M | — | +94.6% |
| SG&A Expense | $25.8M | — | +17.9% |
| Operating Income | $61.8M | — | +447.9% |
| Pre-tax Income | $73.4M | — | +238.0% |
| Income Tax | -$6.9M | — | +31.7% |
| Net Income | $80.3M | — | +152.4% |
| EPS (Basic) | $0.47 | — | +147.4% |
| EPS (Diluted) | $0.44 | — | +144.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $148.3M | -11.5% | +71.6% |
| Accounts Receivable | $134.8M | +62.0% | +93.2% |
| Inventory | $60.2M | +2.0% | +17.8% |
| Current Assets | $1.41B | +3.7% | +31.3% |
| Total Assets | $1.66B | +8.3% | +47.9% |
| Current Liabilities | $125.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $74.6M | — | +610.2% |
| Capital Expenditures | $7.6M | — | +67.1% |
| Investing Cash Flow | -$94.0M | — | -2286.0% |
| Financing Cash Flow | $82K | — | -78.8% |
| Free Cash Flow | $67.0M | — | +1023.4% |
| +61.8% |
| Total Liabilities | $165.3M | -1.7% | +106.2% |
| Stockholders' Equity | $1.49B | +9.6% | +43.4% |